RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire

RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath

Four active cancer center customers are currently purchasing and have made repeat orders of RenovoCath for interventional radiology procedures

Read more at globenewswire.com